Cargando…

Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia

BACKGROUND: Alzheimer’s dementia (AD) is associated with electroencephalography (EEG) abnormalities including in the power ratio of beta to theta frequencies. EEG studies in mild cognitive impairment (MCI) have been less consistent in identifying such abnormalities. One potential reason is not exclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Azami, Hamed, Zrenner, Christoph, Brooks, Heather, Zomorrodi, Reza, Blumberger, Daniel M., Fischer, Corinne E., Flint, Alastair, Herrmann, Nathan, Kumar, Sanjeev, Lanctôt, Krista, Mah, Linda, Mulsant, Benoit H., Pollock, Bruce G., Rajji, Tarek K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405483/
https://www.ncbi.nlm.nih.gov/pubmed/37550778
http://dx.doi.org/10.1186/s13195-023-01280-z
_version_ 1785085541465718784
author Azami, Hamed
Zrenner, Christoph
Brooks, Heather
Zomorrodi, Reza
Blumberger, Daniel M.
Fischer, Corinne E.
Flint, Alastair
Herrmann, Nathan
Kumar, Sanjeev
Lanctôt, Krista
Mah, Linda
Mulsant, Benoit H.
Pollock, Bruce G.
Rajji, Tarek K.
author_facet Azami, Hamed
Zrenner, Christoph
Brooks, Heather
Zomorrodi, Reza
Blumberger, Daniel M.
Fischer, Corinne E.
Flint, Alastair
Herrmann, Nathan
Kumar, Sanjeev
Lanctôt, Krista
Mah, Linda
Mulsant, Benoit H.
Pollock, Bruce G.
Rajji, Tarek K.
author_sort Azami, Hamed
collection PubMed
description BACKGROUND: Alzheimer’s dementia (AD) is associated with electroencephalography (EEG) abnormalities including in the power ratio of beta to theta frequencies. EEG studies in mild cognitive impairment (MCI) have been less consistent in identifying such abnormalities. One potential reason is not excluding the EEG aperiodic components, which are less associated with cognition than the periodic components. Here, we investigate whether aperiodic and periodic EEG components are disrupted differently in AD or MCI vs. healthy control (HC) individuals and whether a periodic based beta/theta ratio differentiates better MCI from AD and HC groups than a ratio based on the full spectrum. METHODS: Data were collected from 44 HC (mean age (SD) = 69.1 (5.3)), 114 MCI (mean age (SD) = 72.2 (7.5)), and 41 AD (mean age (SD) = 75.7 (6.5)) participants. Aperiodic and periodic components and full spectrum EEG were compared among the three groups. Receiver operating characteristic curves obtained via logistic regression classifications were used to distinguish the groups. Last, we explored the relationships between cognitive performance and the beta/theta ratios based on the full or periodic spectrum. RESULTS: Aperiodic EEG components did not differ among the three groups. In contrast, AD participants showed an increase in full spectrum and periodic relative powers for delta, theta, and gamma and a decrease for beta when compared to HC or MCI participants. As predicted, MCI group differed from HC participants on the periodic based beta/theta ratio (Bonferroni corrected p-value = 0.036) measured over the occipital region. Classifiers based on beta/theta power ratio in EEG periodic components distinguished AD from HC and MCI participants, and outperformed classifiers based on beta/theta power ratio in full spectrum EEG. Beta/theta ratios were comparable in their association with cognition. CONCLUSIONS: In contrast to a full spectrum EEG analysis, a periodic-based analysis shows that MCI individuals are different on beta/theta ratio when compared to healthy individuals. Focusing on periodic components in EEG studies with or without other biological markers of neurodegenerative diseases could result in more reliable findings to separate MCI from healthy aging, which would be valuable for designing preventative interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01280-z.
format Online
Article
Text
id pubmed-10405483
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104054832023-08-08 Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia Azami, Hamed Zrenner, Christoph Brooks, Heather Zomorrodi, Reza Blumberger, Daniel M. Fischer, Corinne E. Flint, Alastair Herrmann, Nathan Kumar, Sanjeev Lanctôt, Krista Mah, Linda Mulsant, Benoit H. Pollock, Bruce G. Rajji, Tarek K. Alzheimers Res Ther Research BACKGROUND: Alzheimer’s dementia (AD) is associated with electroencephalography (EEG) abnormalities including in the power ratio of beta to theta frequencies. EEG studies in mild cognitive impairment (MCI) have been less consistent in identifying such abnormalities. One potential reason is not excluding the EEG aperiodic components, which are less associated with cognition than the periodic components. Here, we investigate whether aperiodic and periodic EEG components are disrupted differently in AD or MCI vs. healthy control (HC) individuals and whether a periodic based beta/theta ratio differentiates better MCI from AD and HC groups than a ratio based on the full spectrum. METHODS: Data were collected from 44 HC (mean age (SD) = 69.1 (5.3)), 114 MCI (mean age (SD) = 72.2 (7.5)), and 41 AD (mean age (SD) = 75.7 (6.5)) participants. Aperiodic and periodic components and full spectrum EEG were compared among the three groups. Receiver operating characteristic curves obtained via logistic regression classifications were used to distinguish the groups. Last, we explored the relationships between cognitive performance and the beta/theta ratios based on the full or periodic spectrum. RESULTS: Aperiodic EEG components did not differ among the three groups. In contrast, AD participants showed an increase in full spectrum and periodic relative powers for delta, theta, and gamma and a decrease for beta when compared to HC or MCI participants. As predicted, MCI group differed from HC participants on the periodic based beta/theta ratio (Bonferroni corrected p-value = 0.036) measured over the occipital region. Classifiers based on beta/theta power ratio in EEG periodic components distinguished AD from HC and MCI participants, and outperformed classifiers based on beta/theta power ratio in full spectrum EEG. Beta/theta ratios were comparable in their association with cognition. CONCLUSIONS: In contrast to a full spectrum EEG analysis, a periodic-based analysis shows that MCI individuals are different on beta/theta ratio when compared to healthy individuals. Focusing on periodic components in EEG studies with or without other biological markers of neurodegenerative diseases could result in more reliable findings to separate MCI from healthy aging, which would be valuable for designing preventative interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01280-z. BioMed Central 2023-08-07 /pmc/articles/PMC10405483/ /pubmed/37550778 http://dx.doi.org/10.1186/s13195-023-01280-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Azami, Hamed
Zrenner, Christoph
Brooks, Heather
Zomorrodi, Reza
Blumberger, Daniel M.
Fischer, Corinne E.
Flint, Alastair
Herrmann, Nathan
Kumar, Sanjeev
Lanctôt, Krista
Mah, Linda
Mulsant, Benoit H.
Pollock, Bruce G.
Rajji, Tarek K.
Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
title Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
title_full Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
title_fullStr Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
title_full_unstemmed Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
title_short Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
title_sort beta to theta power ratio in eeg periodic components as a potential biomarker in mild cognitive impairment and alzheimer’s dementia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405483/
https://www.ncbi.nlm.nih.gov/pubmed/37550778
http://dx.doi.org/10.1186/s13195-023-01280-z
work_keys_str_mv AT azamihamed betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT zrennerchristoph betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT brooksheather betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT zomorrodireza betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT blumbergerdanielm betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT fischercorinnee betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT flintalastair betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT herrmannnathan betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT kumarsanjeev betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT lanctotkrista betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT mahlinda betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT mulsantbenoith betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT pollockbruceg betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT rajjitarekk betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia
AT betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia